Details of the Drug

General Information of Drug (ID: DM8VO16)

Drug Name
KH-902
Synonyms Fumintide; KH-902 (intravitreal, AMD/DME), Kanghong Biotechnologies
Indication
Disease Entry ICD 11 Status REF
Diabetic macular edema 9B71.02 Phase 3 [1]
Cross-matching ID
TTD ID
D0O9XO

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Vascular endothelial growth factor receptor (VEGFR) TTVJ1D8 NOUNIPROTAC Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01436864) A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD. U.S. National Institutes of Health.
2 Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats. Diabetes Obes Metab. 2012 Jul;14(7):644-53.